Apella Capital, LLC Precigen, Inc. Transaction History
Apella Capital, LLC
- $2.88 Billion
- Q1 2025
A detailed history of Apella Capital, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Apella Capital, LLC holds 28,985 shares of PGEN stock, worth $43,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,985Holding current value
$43,767% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
141Shares Held
159MCall Options Held
136KPut Options Held
4.8K-
Third Security, LLC83.5MShares$126 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$27 Million1.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$16.4 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$15.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$12.6 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $314M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...